These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7692166)

  • 1. Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function.
    Goldstein M; Vincent JL; De Smet JM; Barvais L; Van Nueten L; Scheijgrond H; d'Hollander A; Leclerc JL; Kahn RJ
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):253-8. PubMed ID: 7692166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
    Ruf G; Trenk D; Jähnchen E; Roskamm H
    Int J Cardiol; 1994 Mar; 43(3):279-85. PubMed ID: 7910155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
    Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
    J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S; Metra M; Dei Cas L
    Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C
    J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial.
    Van Nueten L; Taylor FR; Robertson JI
    J Hum Hypertens; 1998 Feb; 12(2):135-40. PubMed ID: 9504355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
    J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L; Cléroux J; Nadeau A; Lacourcière Y
    J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
    Simon G; Johnson ML
    Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
    Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of nebivolol.
    Mangrella M; Rossi F; Fici F; Rossi F
    Pharmacol Res; 1998 Dec; 38(6):419-31. PubMed ID: 9990650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of the beta blocker nebivolol].
    Rosenkranz S; Erdmann E
    Internist (Berl); 2003 Apr; 44(4):481-2. PubMed ID: 12914405
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure.
    Triposkiadis F; Giamouzis G; Kelepeshis G; Sitafidis G; Skoularigis J; Demopoulos V
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):71-7. PubMed ID: 17323786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
    Arosio E; De Marchi S; Prior M; Zannoni M; Lechi A
    J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension].
    Tuncer M; Fettser DV; Gunes Y; Batyraliev TA; Guntekin U; Gumrukchuoglu KhA; Eryonucu B; Guler N; Sidorenko BA
    Kardiologiia; 2008; 48(4):42-5. PubMed ID: 18447840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age.
    Erdil N; Kaynak M; Dönmez K; Disli OM; Battaloglu B
    Rev Bras Cir Cardiovasc; 2014; 29(4):581-7. PubMed ID: 25714213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
    Lekakis JP; Protogerou A; Papamichael C; Vamvakou G; Ikonomidis I; Fici F; Mavrikakis M
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):277-81. PubMed ID: 16187009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.